Immunologic cross-reactivity between structural proteins of human T-cell lymphotropic virus type I and the blood stage of Plasmodium falciparum
- 1 January 1994
- journal article
- Published by American Society for Microbiology in Clinical and Diagnostic Laboratory Immunology
- Vol. 1 (1) , 5-10
- https://doi.org/10.1128/cdli.1.1.5-10.1994
Abstract
To determine the serologic cross-reactivity between human T-cell lymphotropic virus type I (HTLV-I) and parasite antigens, we measured antibody responses against HTLV-I, Plasmodium falciparum, Plasmodium vivax, and Brugia malayi in serum specimens obtained from regions where malaria (n = 482) and filariasis (n = 101) are endemic. Analysis of immune reactivity to HTLV-I antigens showed that specimens from regions where malaria is endemic had significantly higher rates of enzyme immunoassay (EIA) reactivity (76 of 482 [15.8%] than those from regions where filariasis is endemic (0 of 101 [0%]). Western blot (immunoblot) analysis of the HTLV-I EIA-reactive specimens demonstrated predominant Gag reactivity (HTLV-Iind). Only two specimens each from Indonesia and Brazil and four specimens from Papua New Guinea had Env reactivity by radioimmunoprecipitation analysis. Furthermore, a positive correlation between HTLV-EIA and titers of antibody to the blood stage of P. falciparum (rs = 0.24, P < 0.005) was discerned; no correlation was observed between antibodies to the blood stage or the circumsporozoite protein of P. vivax and the circumsporozoite protein of P. falciparum. In addition, P. falciparum-infected erythrocyte lysate specifically abrogated binding of Gag-specific antibodies in HTLV-Iind specimens from regions where malaria is endemic without affecting binding in HTLV-I-seropositive specimens, suggesting that the immunologic cross-reactivity between HTLV Gag proteins and malaria parasites is restricted to the blood-stage antigens of plasmodia in specimens from regions where malaria is endemic. However, HTLV-seroindeterminate specimens from the United States did not demonstrate serologic cross-reactivity, suggesting that antigenic mimicry of HTLV proteins extends to other nonplasmodial antigens as well.Keywords
This publication has 30 references indexed in Scilit:
- Human sera from varicella-zoster virus (VZV) infections cross-react with human T cell leukaemia virus type 1 (HTLV-1): common epitopes in VZV gene 22 protein and HTLV-1 p19 gag proteinJournal of General Virology, 1992
- Expression of antigen reactive with a monoclonal antibody to HTLV-1 P19 in salivary glands in Sjögren's syndromeClinical and Experimental Immunology, 1992
- Human T-lymphotropic virus type I infection among blood donors in the Solomon IslandsTransfusion, 1992
- Humoral Responses to the ImmunodominantgagandenvEpitopes of Human T-Lymphotropic Virus Type I among MelanesiansViral Immunology, 1992
- Antibodies to Human T Lymphotropic Virus Type I in a Population from the Philippines: Evidence for Cross-Reactivity with Plasmodium falciparumThe Journal of Infectious Diseases, 1991
- HTLV-I INFECTION IN WESTERN EQUATORIAL AFRICAThe Lancet, 1989
- High Prevalence of Serum Antibody Against Human T Cell Leukemia Virus Type I (HTLV-I) Among the Bismam Asmat Population (Indonesian New Guinea)AIDS Research and Human Retroviruses, 1989
- Antibodies to HTLV‐I in populations of the southwestern PacificJournal of Medical Virology, 1988
- Sequence homologies in the control regions of c-myc, c-fos, HTLV and the interleukin-2 receptorCancer Letters, 1985
- Monoclonal antibody to human T-cell leukemia virus P19 defines polypeptide antigen in human choriocarcinoma cells and syncytiotrophoblasts of first-trimester placentasInternational Journal of Cancer, 1984